title: [Combined radiotherapy and chemotherapy as adjuvant treatment of rectal cancer].
abstract: The prognosis following radical operation for rectal cancer is still dubious. There is urgent need for effective adjuvant treatment in order to control both local and distant recurrences. During the last years the use of combined adjuvant treatment (radiochemotherapy ) has increased both recurrence-free survival in several randomised trials. The trials are reviewed in this article. Adjuvant treatment has been recommended as standard therapy in the USA since 1990. Following the German national consensus conference in March 1994, adjuvant treatment is now being recommended in Germany as well. In several other countries in Europe adjuvant therapy is routinely being offered to high-risk colorectal cancer patients following the surgical procedure. The experiences and results that now are available ought to be discussed in the near future in order to establish a national consensus in Denmark.
authors.affiliation: Kirurgisk gastroenterologisk afdeling D., Amtssygehuset i Gentofte.
authors.forename: H H
authors.initials: HH
authors.lastname: Raskov
mesh_terms: D017024:Chemotherapy, Adjuvant; D006801:Humans; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*
vernacular_title: Kombineret stråleterapi og kemoterapi som adjuverende behandling af cancer recti.